1Pharm D, Department of Pharmacy Practice, National College of Pharmacy, Kozhikode, Kerala, India
2Pharm D, Department of Pharmacy Practice, National College of Pharmacy, Kozhikode, Kerala, India
3Pharm D, Department of Pharmacy Practice, National College of Pharmacy, Kozhikode, Kerala, India
4MBBS, DPM, KMCT Medical College Hospital, Kozhikode, Kerala, India
*Corresponding author: Neethu Poulose, National College of Pharmacy, Manassery, Kozhikode, Kerala, India, PIN-673602. neethupoulosemadassery@gmail.com
Online published on 14 January, 2016.
Schizophrenia is one of the leading causes of disability among all health problems. The discrimination and stigma are two unavoidable consequences of schizophrenia that individuals suffer most in developing countries. Management of schizophrenia has been brought out from silent asylums to community, providing them with more care and supports from family, healthcare professionals, and society. This article deals with the important aspects that one comes across while taking care of schizophrenic patients, such as family burden, medication adherence, and pharmacoeconomics. There are many interventions that should be implemented in solving problems associated with management of schizophrenia. Among them, role of psychotherapy and pharmacy-based intervention is unavoidable.
Discrimination, Stigma, Cost Effectiveness, Cost of Illness, Interventions